International Journal of Radiation Oncology Biology Physics

Article	Citations
The R's of Radiation Therapy: Do We Need More or Do We Move On?	209
If Medicine were my Spouse	163
In Regard to Langé et al	155
Spatially Fractionated Radiation Therapy (SFRT) Based on Multimodal Imaging: A Promising Salvage Treatment Strategy for Metastatic and Refractory Cancer Patients	131
The Positioning Accuracy of Individualized Open-Face Mask in Patients with Intracranial Tumors Receiving Radiotherapy - A Randomized Controlled Study	131
“Big Jolts Like an Electric Shock:” Patient Perspectives on the Expectations, Experiences and Quality-of-Life Impact of Androgen Deprivation Therapy (ADT) for Prostate Cancer	113
Can Surface-Guided Radiation Therapy (SGRT) be Used to Monitor Intrafraction Motion of Patients Receiving Accelerated Partial Breast Irradiation (APBI)?	105
The Association of Genetic Polymorphisms in the TNF-α Gene and Mucositis in Head and Neck Cancer Patients Treated with Combined Radiotherapy and Chemotherapy	101
Locoregional Recurrence and Survival Outcome of HER2-Low Breast Cancer Patients after Upfront Surgery and Adjuvant Radiotherapy	88
Applying GD-EOB-DTPA Enhanced MR to Unveil the Radiobiological Effect of Proton and Photon Therapy Based on the Longitudinal Evolution of the Focal Liver Reaction	85
Multi-Modality Machine Learning Prediction Model of Hematologic Toxicity in Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer	85
Development of a Consensus Checklist for Systematic Radiation Treatment Plan Review	83
Withdrawn	77
Partial Kidney Radiation Modeling for the Effect of Kidney Dysfunction in Pediatric Cancer	76
Adoption of Hypofractionated and Ultrahypofractionated Adjuvant Radiation Therapy for Breast Cancer Treatment among Providers at a Large Academic Medical Center	70
Predictive Analysis of DQA (Delivery Quality Assurance) Failures in Tomotherapy Plans: Utilizing Plan Parameters and Dosiomics	70
Clinical Outcomes of Patients with Early-Stage Breast Cancer Treated with Five-Fraction Partial Breast Irradiation vs. Intraoperative Radiation Therapy	68
Personalized Minimal Residual Disease Profiling Predicts Prognosis in Esophageal Carcinoma Undergoing Definitive Radiotherapy	67
A Phase II Trial of 5-Day Neoadjuvant Radiation Therapy for Patients with High-Risk Primary Soft Tissue Sarcoma: Long-Term Follow-Up and Outcomes	66
Evaluating the Efficacy of Novel MET-Targeting Camelid Derived Antibody as an Imaging Agent in Head and Neck Cancers	64
Initial Clinical Experience of Cherenkov Imaging in Sub-Total Total Skin Electron Therapy Identifies Opportunities to Improve Daily Set-Up QA	64
Time-Synchronized Immune-Guided Partial Tumor Irradiation: Proof-of-Principle Trial (NCT04168320)	63
A Microbial-Inspired Antibody-Drug Conjugate Unleashes Macrophage Functionalities for Cancer Immunotherapy	62
Phase I/II Prospective Dose Escalation Trial with Proton-Based Radiation Therapy for Chordomas and Chondrosarcomas of the Skull Base and Cervical Spine: Long-Term Results from Proton Radiation Oncolog	58
Spatiotemporal Fractionation Schemes and Additional OAR Sparing for Single-Beam-per-Fraction FLASH-RT Using Transmission Proton Beam	57

Prostate CAncer Integrated Risk Evaluation (P-CARE): A Model to Stratify Risk of Any, Metastatic, and Fatal Prostate	57
Development of Volumetric Quantitative Evaluation Software for Assessing Respiratory-Induced Target Motion	54
Deep Dive into the Performance of the 5D Breathing Motion Model	52
Feasibility of an Online MR-Guided Scan-Plan-Treat Workflow for Emergency Palliation	52
Adaptive Radiation Fractionation in Head and Neck Cancer through Modeling Tumor Volume Dynamics	51
Assessing Dose Uncertainties in Cardiac SBRT due to Cardiorespiratory Motion: Photon vs. Proton Therapy Comparison	51
Dosimetric Comparison between Intensity Modulated Radiation Therapy and 3-Dimensional Conformal Radiation Therapy in Both Semi-Lateral Decubitus and Supine Positions for Left Breast Cancer Radiation T	51
Lost in Lunglation: Unraveling the Mystery of Idiopathic Pulmonary Syndrome Post-Total Body Irradiation for Bone Marrow Transplant	49
Role of Retreatment with Stereotactic Ablative Body Radiotherapy (SABR) in Oligorecurrent Mesothelioma: A Retrospective Monocentric Study	48
Impact of Resident-Lead Didactics on Referring Trainee Radiotherapy Knowledge and Consultation Comfort	48
Decoding Patient Heterogeneity Influencing Radiation-Induced Brain Necrosis	48
Multi-Omics Sequencing Unveils Tumor Microenvironment Remodeling Induced by Combined Radiotherapy and Immunotherapy in Microsatellite-Stable Locally Advanced Rectal Cancer	47
A Single Arm Phase II Study of Neoadjuvant Chemoradiotherapy and AK104 in pMMR/MSS Locally Advanced Rectal Cancer with Positive PD-L1 Expression	46
Geographical Comparison of Medicare & Medicaid Services (CMS) Standard Charges for Complex Proton Therapy	46
Microboost and Dosimetric Variability in Localized Prostate Cancer: Analysis of a Prospective Statewide Quality Collaborative	46
Transforming into a Trauma-Informed Care Radiation Oncology Department: Training Program Design, Execution and Evaluation of our Program's Impact	46
A Meta-Analysis of Daily vs. Nonconsecutive Fractionation Schedules for Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer	45
Association of Biologically Effective Dose and Survival in Patients Receiving Head and Neck Stereotactic Body Radiation Therapy	45
Timing of Once-Daily Thoracic Radiotherapy and Clinical Outcomes in Patients with Limited-Stage Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy	45
Stereotactic Body Radiation Following Prior Radiotherapy for Pancreatic Cancer: A Single Institution Experience	44
Safety Profile of Durvalumab (D) as Consolidation Treatment (tx) in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) in ADRIATIC: Focus on Pneumonitis and Immune-Mediated Adverse Events (imAEs)	44
Predictors of Local Failure in the Durable Palliation of Recurrent Breast Cancer Following Concurrent Hyperthermia and High Dose Radiation	44
Synergistic Potential of CDK4/6 Inhibitors and Radiotherapy with Anti-PD-L1 Immunotherapy in Triple-Negative Breast Cancer	43
Time-Delayed Contrast-Enhanced T2-FLAIR and Accuracy of GTV Determination in Brain Metastases	43
Local Control of Merkel Cell Carcinoma Treated with Standard of Care Radiation Therapy Compared to Palliative Dose Radiation Therapy	42
Local Disease Control in Patients with Erdheim-Chester Disease Treated with External Beam Radiation Therapy	42
Re-Irradiation in Children with Recurrent Medulloblastoma	41
Long-Term Outcomes after Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer	41
Micro-Costing Analysis of Rectal Spacers in Prostate Cancer Treatment with Radiotherapy	41
Identification of Triapine as a Novel Radiosensitizer in Glioblastoma	41
Mind Over Matter: Complete Craniospinal Irradiation or Just Treat the Spine	40
Managing for Daily Improvement: A System for Real-Time Quality Improvement and Patient Safety	40
Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Radiation Therapy in Two Fractions for Locally Recurrent Prostate Cancer after Definitive Radiation Therapy	40
A Pilot Comparative Study of Mouthbite Devices and Their Effect on Patient Experience and Treatment Setup	40
Accelerated Partial Breast Irradiation for Low-Risk Hormone-Sensitive Breast Cancer is Underutilized but Increasing in the National Cancer Database 2010-2021	40
Reducing Patient Safety Risk with the Implementation of Intradepartmental Survey Program across a Multi-Site Large Teaching Institution	39
Treatment of Patients with Gastric Extranodal Marginal Zone Lymphomas (MZL) Using CBCT-based Adaptive Radiotherapy (ART) to Reduce Margins	39
Developing Blood Sparing Radiotherapy Following CAR T for Lymphoma	39
Risk of Death in Octogenarians with Intermediate Risk Prostate Cancer Who Are Treated with Radiation Therapy (RT) Plus Androgen Deprivation Therapy (ADT) Versus Radiation Alone, an NCDB Analysis	39
Prognostic Factors for Early Demise Following Palliative Spatially Fractionated Radiotherapy	38
The Feasibility Study of Dual-Energy CT Virtual Non-Contrast instead of True Non-Contrast in Proton Radiotherapy Dose Calculation	38
Optimizing Radiation Treatment for Glioblastoma Patients: Contrasting Dosimetric Profiles of HyperArc and Volumetric Arc Therapy	38
Estimating Risk of Biochemical Recurrence after RT Utilizing a Convolutional Neural Network	38
Comparison between Proton LET-Dependent RBE Dose and Photon Physical Dose for Acute Radiation Dermatitis in Caucasian and African-American Breast Cancer Patients Undergoing Radiation Therapy	38
Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local Failure	37
Conventionally Fractionated Reirradiation of Recurrent High-Grade Gliomas: A Look at Dose Escalation and Safety	37
Mid-Range Arc Therapy—Enhancing Dosimetric Quality, Robustness and Efficiency for Proton Treatment with Simple Planning	37
Voxel-Level Dosimetry for Combined Iodine 131 Radiopharmaceutical Therapy and External Beam Radiation Therapy Treatment Paradigms for Head and Neck Cancer	36
Issue Highlights page	36
Artificial Intelligence Auto Contouring and its Impact on Resident Education	36

Proton Craniospinal Irradiation for Patients with Solid Tumor Leptomeningeal Metastasis- Final Analysis of a Phase II Study	36
Interprofessional Teaming: Is a One-hour Novel Didactic/Interactive Leadership Class Feasible?	36
Stereotactic Body Radiotherapy Combined With Lenvatinib With or Without PD-1 Inhibitors as Initial Treatment for Unresectable Hepatocellular Carcinoma	36
Distance Traveled by Patients Globally to Access Radiotherapy: A Systematic Review	35
Performance of Multiparametric MRI and PET Imaging in Identifying and Localizing Locally Radiorecurrent Prostate Cancer in a Phase I/II Trial of Focal Salvage HDR	35
Molecular Changes in Breast Cancer Induced by Radiation Therapy	35
External Beam Radiation therapy After Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone for Treatment of Inoperable Hepatocellular Carcinoma: A Randomized Phase 3 Trial	35
Dose Painting Radiotherapy Guided by Diffusion-Weighted Magnetic Resonance vs. 18F-FDG-PET/CT in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized, Controlled Clinical Trial	35
KDM3B Single-Nucleotide Polymorphisms Impact Radiation Therapy Toxicity Through Circular RNA-Mediated KDM3B Expression and Inflammatory Responses	35
Repeated Carbon-Ion Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma	35
A First Look at Equity, Diversity, and Inclusion of Canadian Medical Physicists: Results From the 2021 COMP EDI Climate Survey	35
Early Normal Tissue Effects and Bone Marrow Relative Biological Effectiveness for an Actinium 225-Labeled HER2/neu-Targeting Antibody	34
A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy	33
Climate-Smart Oncology: Can Hypofractionation Lighten Radiotherapy's Environmental Load?	33
Surgical Status in the Era of New Molecular Diagnostics: Insights from a Single-Center Case Series Report in China	33
Using Holistic Residency Applicant Review and Selection in Radiation Oncology to Enhance Diversity and Inclusion—An ASTRO SCAROP-ADROP-ARRO Collaboration	33
Distance Traveled by Patients Globally to Access Radiation Therapy: A Systematic Review	33
The Impact of Telemedicine on Indirect Patient Costs in an Outpatient Radiation Oncology Department	33
Toxicity Evaluation of Dose-Escalation in Hypofractionated Regional Nodal Irradiation for Breast Cancer: A Retrospective Study	32
Evidence for Persistent Radiation-Related Injury to the Immune System in Patients With Local Breast Cancer	32
Quantifying the Effect of 4-Dimensional Computed Tomography–Based Deformable Dose Accumulation on Representing Radiation Damage for Patients with Locally Advanced Non-Small Cell Lung Cancer Treated wi	32
Doing Our Best With What We Have (and Know)	31
Impact of Deep Learning Auto Segmentation Accuracy on Duodenal Dose-Volume Parameters for Pancreas SBRT Patients Treated with MR-Guided Online Adaptive Radiotherapy	31
Expression of concern to “The Critical Role of Dysregulated RhoB Signaling Pathway in Radioresistance of Colorectal Cancer” Liu et al, Int J Radiat Oncol Biol Phys, 2019;104(5):1153-1164.	31
Beyond Randomized Controlled Trials: Embracing Pragmatism for Evidence-Based Online Adaptive Radiation Therapy	31
In Reply to Onal et al	31
Oligometastatic Head and Neck Squamous Cell Carcinoma: Is SABR the Solution?	31
Trends in Private Equity Involvement in Oncology Practices in the United States	30
Breast Cancer Radiotherapy Experience in a Newly Established Cancer Center in Nigeria	30
A Simple Method to Generate Descriptive Images for Recurrent Cervix Cancer Using Predictive ResNet Model Weights and Feature Maps	30
Dose-Escalated Ablative Radiotherapy as Definitive Treatment for Unresectable and Recurrent Intrahepatic Cholangiocarcinoma	30
Radiation Dose-Volume-Response Relationships for Adverse Events in Childhood Cancer Survivors: Introduction to the Scientific Issues in PENTEC	30
The Onus of Proof: Evidence-Based Adoption of Advanced Radiation Therapy Technologies	30
Salvage Ablative Radiation Therapy for Isolated Intraabdominal Recurrences of Hepatocellular Carcinoma	30
Caught Between a Radiation Oncology Case Rate (ROCR) and a Hard Place: Improving Proposed Radiation Oncology Alternative Payment Models	30
Prognostic Factors of Mandibular Osteoradionecrosis Including Accurate Colocalization of Avulsions and Dosimetric Dental Mapping Software, a Case-control Study	30
In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Abdominal Oligometastases	29
Risk of Diabetes Mellitus after Radiotherapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	29
Hypofractionated vs. Conventionally Fractionated Radiotherapy for Glioblastoma: Peripheral Blood Leukocyte Comparison prior to and Following Chemoradiation	29
Withdrawn	29
Retrospective Analysis of Proton Beam Therapy for Postoperative Locally Recurrent Rectal Cancer	29
Pivotal Roles of Tumor-Draining Lymph Nodes in the Abscopal Effect from Combined Immunotherapy and Radiotherapy	29
The Use of Breast Cup Immobilization in Radiation Therapy and Patient Reported Outcomes on Cosmesis and Pain	28
Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT): A Single Institution, Dose De-Escalation, Phase II Trial	28
NAUTIKA1: A Multicenter Phase II Study with a PD-L1+ Cohort of Patients Receiving Atezolizumab (Atezo) with Low-Dose Stereotactic Body Radiation Therapy (SBRT) as Neoadjuvant Therapy for Resectable St	28
Single Fraction HDR Brachytherapy for Prostate Cancer: SiFEPI Phase II Trial Results	28
The Maximum Standardized Uptake Value in Patients with Recurrent or Persistent Prostate Cancer after Radical Prostatectomy and PSMA-PET-Guided Salvage Radiotherapy – A Multicenter Retrospective Analys	28
Withdrawn	27
A Crowdsourcing Challenge for the Development of Artificial Intelligence Algorithms for Automated Identification and Delineation of Pancreatic Cancer Primary Tumors	27
Brain Metastases in Metastatic Cutaneous Melanoma: Patterns of Care and Clinical Outcomes in the Era of Immunotherapy and Targeted Therapy	27
Comparison of Diagnostic PET and 4D CT-Based Tumor Delineation for Oligometastatic Lung Tumors	27
The Utility of Mean Apparent Diffusion Coefficient Value in Patients with Prostate Cancer Treated with Definitive Radiotherapy	27
Association of Inpatient Radiation Oncology Consult Timing with Length of Hospitalization and Opioid Utilization	27
Outcomes Associated with the Use of Tissue Equivalent Bolus Tailored by Skin Involvement Status in Postmastectomy Radiotherapy: A Single-Blinded Randomized Clinical Trial	27
Improving Interpretability of Machine Learning in Head and Neck Radiation Therapy Pretreatment Physics Plan Reviews	27
Effect of Postmastectomy Radiotherapy in Breast Cancer Patients according to Pathologic Nodal Status and Molecular Subtype after Neoadjuvant Chemotherapy	27
Radiation Necrosis Risk in NSCLC Patients Receiving EGFR TKIs or ALK Inhibitors	26
Clinically Consistent Prostate Cancer Outcome Prediction Models with Machine Learning	26
Does hippocampal atrophy correlate with patient-reported adaptive function one year following radiotherapy? Results from a prospective trial	26
Assessment of Nutritional and Imaging Biomarkers to Predict PEG Tube Placement in Non-HPV-Associated Head and Neck Patients Undergoing Concurrent Chemoradiotherapy	26
Brachytherapy Capacity for Management of Cervical Cancer in Low- and Middle-Income Countries: An Updated IAEA Database Analysis	26
TEAching Mentoring in Radiation Oncology (TEAMRO): a ROECSG GME multi-institutional pilot study on teaching mentorship skills to residents	26
Perineural Invasion Combined with Pattern C of the Silva Classification System Correlates Poor Prognosis in Cervical Adenocarcinoma Following a Radical Hysterectomy	26
Novel Enhancement of Checkpoint Inhibition Using Pulsing Radiotherapy with Concurrent and Adjuvant CPI for LAHNSCC in Elderly Patients Considered Ineligible for Curative Intent Therapy	26
Lymph Node Metastasis Spread Patterns and the Effectiveness of Prophylactic Neck Irradiation in Sinonasal Squamous Cell Carcinoma (SNSCC)	26
Predicting Recurrent Patterns After Radiotherapy Plus Concomitant and Adjuvant Temozolomide in Patients With High-Grade Gliomas Incorporating Multimodal Magnetic Resonance Imaging and Molecular Biomar	26
The LMP1/Lgals1-NF-Kb-IRF1-PDL1 Axis Promotes Immune Escape in Nasopharyngeal Carcinoma	26
Optimal Threshold of Smoking in Pack-Years and its Association with Survival Outcomes Among Patients Treated with Chemoradiation for Head and Neck Cancer	26
A National Cancer Disparities Analysis of Pacific Islanders Who Decline Radiation Therapy and Impacts on Overall Survival	26
Prevalence and Functional Impact of Vertigo among Long Term Survivors of Head and Neck Cancer	26
Combination Treatment of Irradiation and Tumor Treating Fields for Human Glioblastoma Cells	25
Overall Survival after Y-90 Selective Internal Radiotherapy of Liver Metastases in Oligometastatic Patients	25
Meetings page	25
Predictors of Interstitial Brachytherapy Utilization in Locally Advanced Cervical Cancer and Impact on Overall Survival	25
Systematic Implementation of Effective Quality Assurance Processes for the Assessment of Radiation Target Volumes in Head and Neck Cancer	25
Novel Bioprinted Pancreatic Tumor Model: A Translational Tool for Radiotherapy, Chemotherapy and Immunotherapy Efficacy Studies	25
Clinical Outcomes in High Risk WHO Grade II Glioma Patients Treated with Upfront TMZ-Based Chemoradiotherapy	25
Does Operability Status Influence Outcomes in Patients with T4 Larynx Cancer Undergoing Larynx Preservation?	24
Effects of Expansion Size from Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Conventionally Fractionated Radiotherapy for WHO Grade I Meningiomas	24
The Combination of Radiation Therapy and Immunotherapy Is Effective and Well-Tolerated for Unresectable Biliary Tract Cancer	24

Postoperative Radiotherapy can Improve the Disease-Free Survival of EGFR Wild Type Patients with pN2 NSCLC after Complete Resection and Adjuvant Chemotherapy	24
Effectiveness of Adjuvant Radiotherapy for High Recurrence Risk Patients with Upper Tract Urothelial Carcinoma	24
Impact of a Head and Neck Cancer Chemoradiation (HNC CRT) Nurse Practitioner (NP) on Patient Outcomes	24
Evaluation of Patient and Tumor Features to Optimize Urothelial Metastasis Treatment	24
FAST-01: Results of the First-in-Human Study of Proton FLASH Radiotherapy	24
Issue Highlights page	24
Small Molecule Inhibitors Targeting Transgelin-2-Actin Interaction for Therapeutic Intervention in Glioblastoma	24
Combined DNA Damage Repair Interference and Ion Beam Therapy: Development, Benchmark, and Clinical Implications of a Mechanistic Biological Model	24
Cisplatin and Albumin-Based Gold–Cisplatin Nanoparticles Enhance Ablative Radiation Therapy–Induced Antitumor Immunity in Local and Distant Tumor Microenvironment	24
Disease-Free Survival of Patients with Muscle Invasive Bladder Cancer Treated by Radical Cystectomy vs. Bladder-Sparing Therapy at a Nationwide Level	24
Low Utilization of External Beam Radiation Therapy for Patients With Unresectable Hepatocellular Carcinoma: An Analysis of the United Network for Organ Sharing Database	24
Impact of Short-Course Palliative Radiation Therapy on Pancreatic Cancer-Related Pain: Prospective Phase 2 Nonrandomized PAINPANC Trial	23
Deep Learning Based Prognostic Prediction in Oropharyngeal Cancer Patients Using Multiparametric MRI Inputs	23
Mechanisms and Review of Clinical Evidence of Variations in Relative Biological Effectiveness in Proton Therapy	23
Post-Operative Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer with Gammapod™ Technology: A Phase II Clinical Trial	23
Issue Highlights page	23
Real-World Outcomes of Chemoradiation and Consolidative Durvalumab in Unresectable Stage III Non-Small-Cell Lung Cancer — A Systematic Review	23
Radiation Therapy for Meningiomas – Where Do We Stand and What's on the Horizon?	23
A New Pos-SIB-ility for Prostate and Pelvic Nodal Radiation Therapy in High-Risk Localized Prostate Cancer	23
Incidence of Flap Failure Following Sinonasal Surgery, Flap Reconstruction and Postoperative Proton Radiation Therapy	22
Evaluating Heterogeneity of Hippocampal Avoidant Whole Brain Radiotherapy (HA-WBRT) Treatment Effect on Neurocognitive Function (NCF): Secondary Analysis of NRG-CC001	22
Primary Mediastinal B-Cell Lymphoma: The Role of Consolidative Radiation for a “Terrible” Lymphoma	22
Who Knows When it is Right Under Your Nose? A Case of Cutaneous Squamous Cell Carcinoma with Involvement of the Nasal Vestibule	22
Association of Gut Microbiome Characteristics With the Late Gastrointestinal Toxicities After Pelvic Receiving Radiation Treatment for Cervical, Vaginal, and Anal Cancers	22
Maximization of Peak-to-Valley Dose Ratio and Normal-Tissue Survival Fraction for Proton Minibeam Radiation Therapy	22
Arytenoid-Sparing Intensity-Modulated Radiotherapy for Early-Stage Glottic Cancer	22
Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy	22
MC1635: Randomized Phase III Trial of Hypofractionated Radiotherapy to the Whole Breast After Breast Conserving Surgery	22
Deep Learning-Based Automatic Delineation of Target Volumes and Organs at Risk of Breast Cancer for On-Line Dosimetric Evaluation	22
Predictive Ability of Delta Radiomic Texture Features (DRTF) Extracted from Liver Patients Treated With Magnetic Resonance Guided Stereotactic Body Radiotherapy (MRgSBRT)	22
Defining Racial Disparities Across the Prostate Cancer Disease Continuum in an Equal Access-to-Care Setting Within the Nation's Largest Healthcare Network	22
Impact on Pulmonary Function in a Randomized Trial of Single-Fraction and Multifraction Stereotactic Body Radiation Therapy for Pulmonary Oligometastatic Disease: An Analysis of TROG 13.01 (SAFRON II)	22
Less Is More: A Hypofractionated Approach	22
Real Time Volumetric MRI for MR-Guided 3D Motion Tracking via Sparse Prior-Augmented Neural Representation Learning	22
Methylome Analysis of Rare Sinonasal Malignancies: Novel Venues for Clinical Applications	22
Predicting Pathologic Lymph Node Positivity in cN0 Pharynx and Larynx Cancers in the Modern Imaging Era	22
Prognostic Significance of the Novel Nutrition-Inflammation Marker of Lymphocyte-C-Reactive Protein Ratio in Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy	22
Randomized Clinical Trial of Tele-Surveillance and Remote Symptom Monitoring Compared to Standard Surveillance for HPV-Associated Oropharynx Cancer with No Evidence of Disease on Post-Treatment Imagin	22
Machine Learning Algorithm Prospectively Predicts Survival for High-Risk Patients Undergoing Radiotherapy: A Survival Analysis of SHIELD-RT	21
Dosimetric Comparison and Clinical Implications of Dose Calculation Algorithms for Stereotactic Body Radiation Therapy in Spine Metastases	21
Combination of LINAC Auto-Go and SGRT Auto-Positioning as a New Positioning Method for Thoracic Radiotherapy Patients	21
Withdrawn	21
Re-Evaluating Surgery and Re-Irradiation for Locally Recurrent Pediatric Ependymoma — a Multi-Institutional Study	21
The Irradiated Brain Volume Within 12 Gy Is a Predictor for Radiation-Induced Changes After Stereotactic Radiosurgery in Patients With Unruptured Cerebral Arteriovenous Malformations	21
Incidence of Major Depression, Suicidal Ideation, and Mental Health Treatment Amongst Cancer Survivors	21
Patient Factors Associated With Loss to Radiation Oncology Specialty Follow-Up Among Head and Neck Cancer Survivors	21
Less Is More: Lower Doses for Intermediate-Term Oropharyngeal Control	20
NTCP-Driven Comparison of Proton Versus VMAT Approaches for Reducing Hematologic and Gastrointestinal Toxicities in Anal Cancer Patients Receiving Definitive Chemoradiation	20
Deployment of a Deep Learning Automated Cardiac Sub-Structure Contouring Algorithm to Measure Coronary Dose Exposure Trends in Lung Cancer Radiation Therapy	20
A Randomized Controlled Phase Ⅱ Study of Nab-Paclitaxel vs. Paclitaxel plus Cisplatin in Concomitant Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer	20
Outcomes of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) for Adrenal Metastases: A Multi-Institutional Pooled Analysis	20
Survival Outcomes in Primary Angiosarcoma of the Head and Neck: A Systematic Review and Meta-Analysis	20
Largest Real-World Data of Regional Nodal Irradiation Using Ultra-Hypofractionated 5-Fraction Adjuvant Radiation Therapy for Breast Cancer from a Single Institute in India	20
Pre-Clinical Validation of Targeting Cholesterol Metabolism for Radiotherapy Sensitization in Head and Neck Cancer	20
Single Dose vs. Fractionated High-Dose Rate Brachytherapy in Localized Prostate Cancer: Long Term Results	20
The Baseline Serum Lipid Levels and Outcomes of NSCLC Patients Receiving Immunotherapy Combined or Non-Combined with Radiotherapy: A Single Center Retrospective Study	20
IL-1β+ Tumor Associated Macrophages Induced by Type I Interferon Initiates Radiotherapy-Mediated Abscopal Effect	20
First Application of Predictive Model to Assist Adaptive Proton Therapy	20
Genomic and Transcriptomic Remodeling by Neoadjuvant Chemoradiotherapy (nCRT) and the Indicative Role of Acquired INDEL Percentage for nCRT Efficacy in Esophageal Squamous Cell Carcinoma	20
Withdrawn	20
Phase II Clinical Trial of Hypofractionated Image-Guided Proton Therapy with 12 Fractions for Prostate Cancer	20
Assessment of Cardiac Radiation Dose in the Co-60 Prone Based Stereotactic Partial Breast Irradiation (CP-sPBI) Using the Distance from the Heart to the Planning Treatment Volume as a Surrogate Marker	19
Recurrence Dynamics After Complete Resection and Adjuvant Chemotherapy in Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer	19
Withdrawn	19
A Pilot Study of Head and Neck Cancer Patients Treated Daily with an Intraoral Photobiomodulation (PBM) Device while Undergoing IMRT Demonstrates Tolerability, Safety, and Preliminary Efficacy for Red	19
Combination of Radiotherapy and Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study	19
Population-Based Study on the Association Between Autoimmune Disease and Lymphoma: National Health Insurance Service-National Sample Cohort 2002-2015 in Korea	19
In Reply to Goyal and Madan	19
SBRT Treatment Planning Study for the First Clinical Biology-Guided Radiotherapy System	19
Prognostic Significance of Tumor Infiltrating Lymphocytes (TILs) and Programmed Cell Death-Ligand 1 (PD-L1) in Nasopharyngeal Carcinoma	19
Patient-Specific Deep Learning Auto-Segmentation for MR-Guided Adaptive Radiotherapy of Prostate Cancer	19
A Phase 2 Multi-Center, Placebo-Controlled, Randomized Study to Assess the Safety and Efficacy of Parenteral TK-90 for Preventing Radiation-Induced Mucositis in Patients with Squamous Cell Carcinoma o	19
Identification and Dosimetric Analysis of Axillary Substructures Associated with Breast Cancer Related Lymphedema	19
Clinical Outcomes After Trimodality Therapy With Dose-Escalated Neoadjuvant Intensity-Modulated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer	19
A Molecular Approach to Characterize the Effects of Fluence, Fluence Rate and LET on Radiation Damage	19
The Impact of TP53 Mutations and Use of the TP53-Mutation-Reactivating Agent APR-246 on Metastatic Castrate-Sensitive Prostate Cancer	19
International Clinical Radiotherapy Audit in CCCN- iPAAC Project	19
Cord Blood–Derived Endothelial Progenitor Cells Promote In Vivo Regeneration of Human Hematopoietic Bone Marrow	19
How the Underlying Etiology of Cirrhosis Impacts Response to SBRT	19
Correlation between Lymph Node Regression Grading and Tumor Regression Grading after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer	19
Interpretable Deep Learning Identified the Significance of 1 Gy Volume on Lymphopenia after Radiotherapy in Breast Cancer	19
Wireless Device for Adaptive Planning Based Upon Thermoacoustic Range Estimates ― Design and Benchtop Validation	19
Intraoral Gavage of Second-Generation Probiotic Lactobacillus Reuteri Releasing IFN-β (LR-IFN-β) Mitigates Intestinal Irradiation Toxicity and Improves Survival During Whole Abdomen Irradiation (WAI)	18
Clinical Outcomes in cN+M0 Bladder Cancer Patients: Can Bladder be Spared?	18
Withdrawn	18
Toxicity Outcomes at 18 Months for Cs-131 Low-Dose-Rate Prostate Brachytherapy Compared to I-125 and Pd-103	18
Advancing beyond the Hippocampus to Preserve Cognition for Patients with Brain Metastases: Dosimetric Results from a Phase 2 Trial of Memory-Avoidance Whole Brain Radiotherapy	18
Accelerated Partial Breast Irradiation (APBI) Using Five Daily Fractions: A Prospective, Phase II, Multi-Center Trial of Cosmetic Outcomes and Toxicity: Final Results	18
Improving the Efficacy and Safety of Concurrent Chemoradiotherapy by Neoadjuvant Chemotherapy: A Randomized Controlled Study of Locally Advanced Cervical Cancer with a Large Tumor	18
Communicating the External Beam Radiotherapy Experience (CEBRE) Discussion Guides: Real World Implementation and Evaluation	18
Evaluating the Use of SGRT and Abdominal Compression Device for Improved Patient Positioning in Liver Cancer Radiotherapy	18
Association between Liver Metastases and Treatment Response in Patients with Metastatic, Microsatellite Stable Colorectal Cancer Treated with Radiation Therapy and Dual Immune Checkpoint Blockade	18
Atypical Nodal Involvement From an Atypical Meningioma	18
Geometric and Dosimetric Evaluation of Using a Novel Tongue Positioning Device to Reduce Tongue Motions during Radiation Therapy for Head and Neck Cancer	18
Long Term Results of Prostate Cancer Patients Treated with Cs131 LDR Brachytherapy Compared with Recently Published SBRT Data	18